Vir Biotechnology, Inc. (NASDAQ:VIR) today announced it will present new data from the Phase 2 SOLSTICE clinical trial ...
Approximately 4–5 million HIV-infected patients are coinfected with HCV. HIV–HCV coinfection is associated with a higher HCV RNA load and rapid disease progression to cirrhosis compared with ...
Self-care technologies are key for improving health and well-being — and for reaching universal health coverage by 2030.
Magnus Lindh's group studies hepatitis B and hepatitis D with a focus on pathogenesis and viral mechanisms. Hepatitis B is a major global health problem despite access to an effective vaccine. Chronic ...
There are no specific treatments for hepatitis A, a liver disease that’s caused by the hepatitis A virus and marked by inflammation of the liver. The virus is most often transmitted via ...
Several things can cause hepatitis, including microbes, harmful substances, and medical conditions. The most common form of hepatitis is viral hepatitis, brought on by viruses hepatitis B and C. Other ...
The Hepatitis D drugs in development market research report provides comprehensive information on the therapeutics under development for Hepatitis D, complete with analysis by stage of development, ...
However, there’s one vitamin that (despite eating healthily) you simply have to supplement in autumn and winter: vitamin D. Due to shorter days and lack of sun exposure, experts say we can all ...
People aged 16 and over who receive routine blood tests when they attend Sheffield’s Northern General Hospital A&E department are to be tested for HIV, hepatitis B and hepatitis C, regardless of ...
ABSTRACT: Background: The World Health Organization (WHO) has set a goal to eradicate or at least significantly reduce the prevalence the human immunodeficiency virus (HIV), hepatitis B Virus (HBV) ...
ABSTRACT: Background: The World Health Organization (WHO) has set a goal to eradicate or at least significantly reduce the prevalence the human immunodeficiency virus (HIV), hepatitis B Virus (HBV) ...